RapidAI earns FDA clearance for Rapid Aortic product
SAN MATEO, Calif. — Nov 19: RapidAI, the pioneer of deep clinical AI and global leader in enterprise imaging, today announced U.S. Food and Drug Administration (FDA) clearance of Aortic Management, part of the Rapid Aortic product, a comprehensive deep clinical AI solution designed to transform the acute assessment and longitudinal management of aortic disease. RapidAI remains […]
RapidAI earns FDA clearance for Rapid Aortic product Read More »
